Generic Name: Empagliflozin and LinagliptinDosage Form: TabletTG Name: Endocrine & Diabetes 1. What is EMPALINA®?EMPALINA® is a combination of Empagliflozin, a Sodium-glucose cotransporter-2 (SGLT2) inhibitor and Linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is […]